GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SOFIVA GENOMICS Co Ltd (ROCO:6615) » Definitions » Cash, Cash Equivalents, Marketable Securities

SOFIVA GENOMICS Co (ROCO:6615) Cash, Cash Equivalents, Marketable Securities : NT$127.2 Mil (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is SOFIVA GENOMICS Co Cash, Cash Equivalents, Marketable Securities?

SOFIVA GENOMICS Co's quarterly cash, cash equivalents, marketable securities increased from Sep. 2024 (NT$136.18 Mil) to Dec. 2024 (NT$146.18 Mil) but then stayed the same from Dec. 2024 (NT$146.18 Mil) to Mar. 2025 (NT$127.18 Mil).

SOFIVA GENOMICS Co's annual cash, cash equivalents, marketable securities declined from Dec. 2022 (NT$170.96 Mil) to Dec. 2023 (NT$140.03 Mil) but then increased from Dec. 2023 (NT$140.03 Mil) to Dec. 2024 (NT$146.18 Mil).


SOFIVA GENOMICS Co Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for SOFIVA GENOMICS Co's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SOFIVA GENOMICS Co Cash, Cash Equivalents, Marketable Securities Chart

SOFIVA GENOMICS Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 219.05 245.19 170.96 140.03 146.18

SOFIVA GENOMICS Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 119.25 123.42 136.18 146.18 127.18

SOFIVA GENOMICS Co Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


SOFIVA GENOMICS Co  (ROCO:6615) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


SOFIVA GENOMICS Co Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of SOFIVA GENOMICS Co's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


SOFIVA GENOMICS Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 66-1, Section 1, Chongqing S. Road, 4th Floor, Zhongzheng District, Taipei, TWN, 10043
SOFIVA GENOMICS Co Ltd provides medical diagnostic services. The services offered by the company include Prenatal, Reproductive, Cancer, Precision Medicine, Newborn, and Rare Diseases. Its testing categories include Genetic, Biochemical, and Chromosome. The business items of Sofiva Group are pre-pregnancy, prenatal, and neonatal genetic testing and medical testing, and other service income. Geographically, it generates the vast majority of its revenue from Taiwan.

SOFIVA GENOMICS Co Headlines

No Headlines